RT Journal Article
T1 Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study.
A1 Chaparro, María
A1 Garre, Ana
A1 Núñez Ortiz, Andrea
A1 Diz-Lois Palomares, María Teresa
A1 Rodríguez, Cristina
A1 Riestra, Sabino
A1 Vela, Milagros
A1 Benítez, José Manuel
A1 Fernández Salgado, Estela
A1 Sánchez Rodríguez, Eugenia
A1 Hernández, Vicent
A1 Ferreiro-Iglesias, Rocío
A1 Ponferrada Díaz, Ángel
A1 Barrio, Jesús
A1 Huguet, José María
A1 Sicilia, Beatriz
A1 Martín-Arranz, María Dolores
A1 Calvet, Xavier
A1 Ginard, Daniel
A1 Alonso-Abreu, Inmaculada
A1 Fernández-Salazar, Luis
A1 Varela Trastoy, Pilar
A1 Rivero, Montserrat
A1 Vera-Mendoza, Isabel
A1 Vega, Pablo
A1 Navarro, Pablo
A1 Sierra, Mónica
A1 Cabriada, José Luis
A1 Aguas, Mariam
A1 Vicente, Raquel
A1 Navarro-Llavat, Mercè
A1 Echarri, Ana
A1 Gomollón, Fernando
A1 Guerra Del Río, Elena
A1 Piñero, Concepción
A1 Casanova, María José
A1 Spicakova, Katerina
A1 Ortiz de Zarate, Jone
A1 Torrella Cortés, Emilio
A1 Gutiérrez, Ana
A1 Alonso-Galán, Horacio
A1 Hernández-Martínez, Álvaro
A1 Marrero, José Miguel
A1 Lorente Poyatos, Rufo
A1 Calafat, Margalida
A1 Martí Romero, Lidia
A1 Robledo, Pilar
A1 Bosch, Orencio
A1 Jiménez, Nuria
A1 Esteve Comas, María
A1 Duque, José María
A1 Fuentes Coronel, Ana María
A1 Josefa Sampedro, Manuela
A1 Sesé Abizanda, Eva
A1 Herreros Martínez, Belén
A1 Pozzati, Liliana
A1 Fernández Rosáenz, Hipólito
A1 Crespo Suarez, Belén
A1 López Serrano, Pilar
A1 Lucendo, Alfredo J
A1 Muñoz Vicente, Margarita
A1 Bermejo, Fernando
A1 Ramírez Palanca, José Joaquín
A1 Menacho, Margarita
A1 Carmona, Amalia
A1 Camargo, Raquel
A1 Torra Alsina, Sandra
A1 Maroto, Nuria
A1 Nerín de la Puerta, Juan
A1 Castro, Elena
A1 Marín-Jiménez, Ignacio
A1 Botella, Belén
A1 Sapiña, Amparo
A1 Cruz, Noelia
A1 Forcelledo, José Luis F
A1 Bouhmidi, Abdel
A1 Castaño-Milla, Carlos
A1 Opio, Verónica
A1 Nicolás, Isabel
A1 Kutz, Marcos
A1 Abraldes Bechiarelli, Alfredo
A1 Gordillo, Jordi
A1 Ber, Yolanda
A1 Torres Domínguez, Yolanda
A1 Novella Durán, María Teresa
A1 Rodríguez Mondéjar, Silvia
A1 Martínez-Cerezo, Francisco J
A1 Kolle, Lilyan
A1 Sabat, Miriam
A1 Ledezma, Cesar
A1 Iyo, Eduardo
A1 Roncero, Óscar
A1 Irisarri, Rebeca
A1 Lluis, Laia
A1 Blázquez Gómez, Isabel
A1 Zapata, Eva María
A1 José Alcalá, María
A1 Martínez Pascual, Cristina
A1 Montealegre, María
A1 Mata, Laura
A1 Monrobel, Ana
A1 Hernández Camba, Alejandro
A1 Hernández, Luis
A1 Tejada, María
A1 Mir, Alberto
A1 Galve, María Luisa
A1 Soler, Marta
A1 Hervías, Daniel
A1 Gómez-Valero, José Antonio
A1 Barreiro-de Acosta, Manuel
A1 Rodríguez-Artalejo, Fernando
A1 García-Esquinas, Esther
A1 Gisbert, Javier P
A1 The EpidemIBD Study Group Of Geteccu, 
K1 Crohn’s disease
K1 epidemiology
K1 incidence
K1 inflammatory bowel disease
K1 ulcerative colitis
AB (1) Aims: To assess the incidence of inflammatory bowel disease (IBD) in Spain, to describe the main epidemiological and clinical characteristics at diagnosis and the evolution of the disease, and to explore the use of drug treatments. (2) Methods: Prospective, population-based nationwide registry. Adult patients diagnosed with IBD-Crohn's disease (CD), ulcerative colitis (UC) or IBD unclassified (IBD-U)-during 2017 in Spain were included and were followed-up for 1 year. (3) Results: We identified 3611 incident cases of IBD diagnosed during 2017 in 108 hospitals covering over 22 million inhabitants. The overall incidence (cases/100,000 person-years) was 16 for IBD, 7.5 for CD, 8 for UC, and 0.5 for IBD-U; 53% of patients were male and median age was 43 years (interquartile range = 31-56 years). During a median 12-month follow-up, 34% of patients were treated with systemic steroids, 25% with immunomodulators, 15% with biologics and 5.6% underwent surgery. The percentage of patients under these treatments was significantly higher in CD than UC and IBD-U. Use of systemic steroids and biologics was significantly higher in hospitals with high resources. In total, 28% of patients were hospitalized (35% CD and 22% UC patients, p
SN 2077-0383
YR 2021
FD 2021-06-29
LK https://hdl.handle.net/10668/25304
UL https://hdl.handle.net/10668/25304
LA en
DS RISalud
RD Apr 12, 2025